Nanoassemblies Derived from Natural Flavonoid Compounds as New Antioxidant Oral Preparations for Targeted Inflammatory Bowel Disease Therapy
- 26 June 2023
- journal article
- research article
- Published by Wiley in Advanced Functional Materials
- Vol. 33 (45)
Abstract
Possessing the largest surface area of mucosa in the body, the gastrointestinal (GI) tract can easily sufferfrom inflammatory damage under various adverse external exposures, resulting in the occurrence of inflammatory bowel disease (IBD). Excessive reactive oxygen species (ROS) usually lead to local mucosal injury, accelerate the formation of niduses, andamplify the inflammatory and immune response. Antioxidant therapy, therefore, is considered as a potential strategy against IBDs. Herein, a series of novel dihydromyricetin‐based nanoassemblies with excellent antioxidant activities and high dispersion in GI tract as oral preparations are developed for the targeted IBD treatment. By changing raw materials, the current strategy can be well extended to the preparation of other insoluble natural flavonoid compound‐based nanoassemblies. The well‐designed dihydromyricetin‐PEG 1000‐based nanoassemblies (DMY‐1000 NAs) with high stability and great ROS scavenging capacity in the harsh environment of GI tract hold an admirable targeted capability toward the intestinal inflamed lesions. Therefore, these biocompatible DMY‐1000 NAs show promising therapeutic effects for typical IBDs including ulcerative colitis and Crohn's disease in murine models. This study not only provides a new method for constructing antioxidant therapy platforms but also illustrates their prominent therapeutic promise against IBDs.Keywords
Funding Information
- National Natural Science Foundation of China (22075011, 22178140, 52073015)
- Fundamental Research Funds for the Central Universities (BUCT‐PT‐2021‐05)
This publication has 83 references indexed in Scilit:
- Oxidative stress in ulcerative colitis: an old concept but a new concernFree Radical Research, 2012
- Antioxidant and Anti-inflammatory Activities of Selected Medicinal Plants Containing Phenolic and Flavonoid CompoundsJournal of Agricultural and Food Chemistry, 2011
- Genetics and pathogenesis of inflammatory bowel diseaseNature, 2011
- Intestinal homeostasis and its breakdown in inflammatory bowel diseaseNature, 2011
- New pathophysiological insights and modern treatment of IBDJournal of Gastroenterology, 2010
- Inflammatory Bowel DiseaseAnnual Review of Immunology, 2010
- Intestinal mucosal barrier function in health and diseaseNature Reviews Immunology, 2009
- Transferrin as a Luminal Target for Negatively Charged Liposomes in the Inflamed Colonic MucosaMolecular Pharmaceutics, 2009
- Antioxidative Activities of Natural Compounds Found in PlantsJournal of Agricultural and Food Chemistry, 1997
- Oxidants and free radicals in inflammatory bowel diseaseThe Lancet, 1994